Notice of Preapplication Webinar for NOSI NOT-CA-24-033: Telehealth Research in Cancer Care
Notice Number:
NOT-CA-24-045

Key Dates

Release Date:

April 25, 2024

Related Announcements

  • February 23, 2024 - Notice of Special Interest (NOSI): Telehealth Research in Cancer Care. See NOSI NOT-CA-24-033 

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice of Pre-application Webinar for NOT-CA-24-033 is to highlight the interest of NCI’s Division of Cancer Control and Population Sciences in receiving investigator-initiated applications for proposing research on the use and impact of telehealth in cancer-related care, and the implications of telehealth policy changes on cancer care access, outcomes, and health equity.

The pre-application webinar will be held on Monday, May 13, 2024, from 1:00 pm - 1:30 pm ET. 

The pre-application webinar will provide overall information about the notice of special interest (NOSI) NOT-CA-24-033 and address any special requirements for applications submitted to this funding opportunity including NCI behavioral and healthcare delivery research priorities surrounding patient-provider interactions, provider-provider interactions, and the impact of changes in telehealth policy on cancer care access, patient outcomes, and health equity. The webinar will conclude with an open question and answer session. Potential applicants are encouraged to submit their questions in advance to NCIHDRP@mail.nih.gov.
 

Note: Questions about the scope of the NOSI will be addressed during the webinar; however, questions about investigators' specific study aims will not be addressed in the webinar and can be directed to one of the points of contact for this NOSI.
 

Registration for the webinar is required. Register at https://healthcaredelivery.cancer.gov/media/NOT-CA-24-033.html


Following this webinar, NCI DCCPS will link to a recording on https://healthcaredelivery.cancer.gov/media/NOT-CA-24-033.html.  

Inquiries

Please direct all inquiries to:

Please direct all inquiries to NCIHDRP@mail.nih.gov.